Cellebrite Guardian
LeaderTransformation for the Age of Digital Investigations
Est 1999|Valuation $4.1B|Raised $410M
Published Oct 20, 2026
| Starting Price | Not publicly listed; public procurement examples exist for certain agencies (scope unclear) | Public pricing varies by context; some public listings exist for specific offerings | Pricing typically via enterprise quote; not publicly listed in general sources |
| Best For | Organizations needing UFDR-native browser review and DFU-oriented workflows | Agencies standardizing on the Axon ecosystem (body-worn cameras, evidence management) | Organizations invested in the Magnet AXIOM workflow that prefer Magnet’s review tooling |
| Key Strength | Integration with Cellebrite extraction formats and DFU workflow focus; regional hosting options reported | Broad adoption across multiple agencies; integrated ecosystem for evidence types | Practitioner-reported preference for reviewer UX and support in some regions; tight integration with Magnet analysis tools |
| Key Weakness | Pricing opacity; potential workflow friction related to uploads; AI governance concerns to be addressed | Contract complexity and potential ecosystem lock-in | Pricing opacity; dependent on the Magnet ecosystem and licensing model |
Guardian is functionally differentiated in vendor materials by support for native UFDR browser review and DFU-style workflow features. In many agencies, Axon or other DEMS platforms serve as the system-of-record for broader evidence types, while mobile-extraction review products are used to present extracted device data to non-technical stakeholders.
Practitioner commentary indicates that some users prefer Magnet’s approach for the reviewer experience and support model; such observations are anecdotal and may reflect regional reseller engagement as well as product capabilities.
Vendor roadmap statements indicate expansion of cloud-region coverage and additional product modules intended to broaden use cases beyond laboratory-only workflows.